1Kaste M,Hacke W,Fieschi C,et al.Results of the European Cooperative Acute Stroke Study(ECASS)[].Cerebrovascular Diseases.1995
2Hsia AW,Sachdev HS,Tomlinson J,et al.Efficacy of IV tissue plasminogen activator in acute stroke:doesstroke subtype really matter-[].Neurology.2003
3Davis SM,Donnan GA,Parsons MW,et al.Effects of alteplase beyond3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial(EPITHET):a placebo-controlled randomised trial[].The Lancet Neurology.2008
4Wahlgren N,Ahmed N,Dávalos A,et al.Thromboly-sis with alteplase3-4.5h after acute ischaemic stroke(SITS-ISTR):an observational study[].The Lancet.2008
5Hacke W,Kaste M,Bluhmki E,et al.for the ECASS investigators.Thrombolysis with Alteplase3to4.5hours after acute ischemic stroke[].The New England Journal of Medicine.2008
6Lyden P.Thrombolytic therapy for acute stroke--not a moment to lose[].The New England Journal of Medicine.2008
7Ergin A,Ergin N.Is thrombolytic therapy associated with increased mortality? Meta-analysis of random ized controlled trials[].Archives of Neurology.2005
8Hacke W,Kaste M,Fieschi C,et al.Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke(ECASS II)Second European-Australasian Acute Stroke Study In-vestigators[].The Lancet.1998
9Clark WM,Wissman S,Albers GW,et al.Recombinant tissue-type plasminogen activator(Alteplase)for ischemic stroke3to5hours after symptom onset.The ATLANTIS Study:a randomized con-trolled trial.Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke[].The Journal of The American Medical Association.1999
10Albers G W,Bates V E,Clark W M,et al.Intravenous tissue type plasminogen activator for treatment of acute stroke: the standard treatment with alteplase to reverse stroke(STARS) study[].The Journal of The American Medical Association.2000
